Clinical Trials Arena March 18, 2024
The IDgenix test can be used to make medication recommendations to avoid drug-gene and drug-drug interactions in older patients taking multiple medications.
US-based Castle Biosciences has presented new data showing its IDgenetix pharmacogenomic (PGx) test can be used to provide medication recommendations for patients with mental health conditions aged 65 years and older.
The data was presented at the 2024 American Association for Geriatric Psychiatry (AAGP) Annual Meeting in Atlanta in 15-18 March. IDgenetix is a three-in-one PGx test that incorporates genetic information, drug-drug interactions, and lifestyle factors to help clinicians personalise medications for patients with mental health disorders such as depression, anxiety, and other neuropsychiatric illnesses.
“Pharmacogenomics has been increasingly used to identify genetic variations associated with drug response;...
Today's Sponsors
Today's Sponsor